Tapewire

Nasdaq · USD

RARE

Ultragenyx Pharmaceutical Inc.

Export transactions ↓
Tapewire entity
4337
SEC CIK
0001515673
Parsed reports
478

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202502
Jan 202601
Feb 202601
Mar 2026011
Apr 202601
May 202603
Jun 202603
Jul 202601
Aug 202602
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 19, 2022 Filed Apr 22, 2022 12:31 UTC
Ray AmritDirector
GrantStock Option (Right to Buy) · Derivative 9,525 $0.00 Strike: $78.10 $0.00
Disclosure

SEC source: 0001209191-22-025279 · doc4.xml · derivative · entry 2

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,525

Underlying: Common Stock · 9,525 shares

Expires 2032-04-19

F3 · derivative.exercise_date: The option shall vest with respect to 1/36th of the shares monthly such that the option shall be fully vested on the third anniversary of the grant date.

Read SEC document
April 19, 2022 Filed Apr 22, 2022 12:31 UTC
Ray AmritDirector
GrantCommon Stock 5,120 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-025279 · doc4.xml · nonDerivative · entry 1

Ray Amrit · CIK 0001924797 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,120

F1 · shares: Award of Restricted Stock Units ("RSUs") under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/3rd of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the third anniversary of the grant date.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
April 16, 2022 Filed Apr 19, 2022 16:56 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 132 $84.55 $11,160.60
Disclosure

SEC source: 0001209191-22-024699 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,914

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 11, 2022 Filed Mar 15, 2022 20:33 UTC SaleCommon Stock 10,281 $67.01 $688,929.81
Disclosure

SEC source: 0001209191-22-018829 · doc4.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,559

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.00 to $67.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 07, 2022 Filed Mar 8, 2022 17:25 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 5,140 $62.95 $323,563.00
Disclosure

SEC source: 0001209191-22-016931 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,438

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.89 to $63.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 04, 2022 Filed Mar 8, 2022 17:25 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $40.37 $0.00
Disclosure

SEC source: 0001209191-22-016930 · doc4.xml · derivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,500 shares

Expires 2024-07-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested in full on on June 18, 2015.

Read SEC document
March 04, 2022 Filed Mar 8, 2022 17:25 UTC Exercise / conversionCommon Stock 7,500 $40.37 $302,775.00
Disclosure

SEC source: 0001209191-22-016930 · doc4.xml · nonDerivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 03, 2022 Filed Mar 3, 2022 23:12 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 420 $64.55 $27,111.00
Disclosure

SEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 3

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,808

F3 · kind: The sales on March 3, 2022 reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015806 · doc4.xml · derivative · entry 3

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015806 · doc4.xml · nonDerivative · entry 2

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 227,840

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC SaleCommon Stock 2,374 $66.62 $158,155.88
Disclosure

SEC source: 0001209191-22-015806 · doc4.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213,840

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
KAKKIS EMIL DDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 92,360 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015799 · doc4.xml · derivative · entry 4

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,360

Underlying: Common Stock · 92,360 shares

Expires 2032-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
KAKKIS EMIL DDirector · President & CEO
GrantCommon Stock 52,041 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015799 · doc4.xml · nonDerivative · entry 2

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 634,226

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:06 UTC
KAKKIS EMIL DDirector · President & CEO
Tax withholdingCommon Stock 12,162 $67.37 $819,353.94
Disclosure

SEC source: 0001209191-22-015799 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 582,185

F1 · kind: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015802 · doc4.xml · derivative · entry 3

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC
Bedrosian Camille LEVP and Chief Medical Officer
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015802 · doc4.xml · nonDerivative · entry 2

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,938

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:07 UTC
Bedrosian Camille LEVP and Chief Medical Officer
SaleCommon Stock 2,821 $66.62 $187,935.02
Disclosure

SEC source: 0001209191-22-015802 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,938

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:12 UTC
Dier MardiCFO & Executive Vice President
GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015833 · doc4.xml · derivative · entry 4

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:12 UTC
Dier MardiCFO & Executive Vice President
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 2

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,228

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:12 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 534 $66.62 $35,575.08
Disclosure

SEC source: 0001209191-22-015833 · doc4.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,228

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Harris ErikEVP & Chief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015830 · doc4.xml · derivative · entry 3

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Harris ErikEVP & Chief Commercial Officer
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015830 · doc4.xml · nonDerivative · entry 2

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,317

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:11 UTC
Harris ErikEVP & Chief Commercial Officer
SaleCommon Stock 2,713 $66.62 $180,740.06
Disclosure

SEC source: 0001209191-22-015830 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,317

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:10 UTC GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015823 · doc4.xml · derivative · entry 3

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F4 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:10 UTC GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015823 · doc4.xml · nonDerivative · entry 2

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,266

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:10 UTC SaleCommon Stock 4,498 $66.62 $299,656.76
Disclosure

SEC source: 0001209191-22-015823 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,266

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantStock Option (Right to Buy) · Derivative 7,400 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015819 · doc4.xml · derivative · entry 3

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,400

Underlying: Common Stock · 7,400 shares

Expires 2032-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
GrantCommon Stock 3,710 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015819 · doc4.xml · nonDerivative · entry 2

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,046

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes 107 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 843 $66.62 $56,160.66
Disclosure

SEC source: 0001209191-22-015819 · doc4.xml · nonDerivative · entry 1

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,229

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015815 · doc4.xml · derivative · entry 3

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015815 · doc4.xml · nonDerivative · entry 2

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,040

F2 · shares: Award of RSUs under the Company's 2014 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date.

F3 · balance_after: Includes 126 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:09 UTC SaleCommon Stock 3,234 $66.62 $215,449.08
Disclosure

SEC source: 0001209191-22-015815 · doc4.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,914

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantStock Option (Right to Buy) · Derivative 24,900 $0.00 Strike: $67.37 $0.00
Disclosure

SEC source: 0001209191-22-015811 · doc4.xml · derivative · entry 3

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,900

Underlying: Common Stock · 24,900 shares

Expires 2032-03-01

F5 · derivative.exercise_date: On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-015811 · doc4.xml · nonDerivative · entry 2

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,578

F3 · balance_after: Includes 106 shares acquired under the Company's 2014 Employee Stock Purchase Plan on October 29, 2021.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
March 01, 2022 Filed Mar 3, 2022 23:08 UTC
Parschauer Karah HerdmanEVP and Chief Legal Officer
SaleCommon Stock 2,886 $66.62 $192,265.32
Disclosure

SEC source: 0001209191-22-015811 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,472

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.62 to $66.63 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 30, 2022 Filed Feb 1, 2022 18:39 UTC
Bedrosian Camille LEVP and Chief Medical Officer
SaleCommon Stock 1,657 $66.30 $109,859.10
Disclosure

SEC source: 0001209191-22-005838 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,759

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
December 10, 2021 Filed Feb 1, 2022 18:42 UTC GiftCommon Stock 52 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005840 · doc5.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,214

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
December 10, 2021 Filed Feb 1, 2022 18:41 UTC
KAKKIS EMIL DDirector · President & CEO
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-22-005839 · doc5.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200

Disclosed balance after: 2,209,741

Read SEC document
October 14, 2021 Filed Oct 14, 2021 22:33 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 3,261 $81.16 $264,662.76
Disclosure

SEC source: 0001209191-21-060504 · doc4.xml · nonDerivative · entry 2

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,762

F2 · kind: The transaction reported in this row on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.55 to $81.81 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:48 UTC SaleCommon Stock 286 $81.14 $23,206.04
Disclosure

SEC source: 0001209191-21-060754 · doc4.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,266

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:44 UTC
KAKKIS EMIL DDirector · President & CEO
Tax withholdingCommon Stock 853 $81.00 $69,093.00
Disclosure

SEC source: 0001209191-21-060749 · doc4.xml · nonDerivative · entry 1

KAKKIS EMIL D · CIK 0001248093 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 594,347

F1 · kind: Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 23:02 UTC
Bedrosian Camille LEVP and Chief Medical Officer
SaleCommon Stock 359 $81.14 $29,129.26
Disclosure

SEC source: 0001209191-21-060765 · doc4.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,416

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:58 UTC
Harris ErikEVP & Chief Commercial Officer
SaleCommon Stock 303 $81.14 $24,585.42
Disclosure

SEC source: 0001209191-21-060760 · doc4.xml · nonDerivative · entry 1

Harris Erik · CIK 0001780113 · EVP & Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,030

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:55 UTC
Huang Dennis KarlEVP & Chief Tech Ops Officer
SaleCommon Stock 358 $81.14 $29,048.12
Disclosure

SEC source: 0001209191-21-060759 · doc4.xml · nonDerivative · entry 1

Huang Dennis Karl · CIK 0001641217 · EVP & Chief Tech Ops Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,148

F1 · kind: Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:53 UTC
Huizenga Theodore AlanSVP, Chief Accounting Officer
SaleCommon Stock 140 $81.14 $11,359.60
Disclosure

SEC source: 0001209191-21-060756 · doc4.xml · nonDerivative · entry 2

Huizenga Theodore Alan · CIK 0001603347 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,072

F1 · kind: Represents shares sold by the Reporting Person to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:46 UTC
Parschauer Karah HerdmanEVP and General Counsel
SaleCommon Stock 310 $81.14 $25,153.40
Disclosure

SEC source: 0001209191-21-060752 · doc4.xml · nonDerivative · entry 1

Parschauer Karah Herdman · CIK 0001677455 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,358

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 14, 2021 Filed Oct 18, 2021 22:41 UTC SaleCommon Stock 358 $81.14 $29,048.12
Disclosure

SEC source: 0001209191-21-060748 · doc4.xml · nonDerivative · entry 1

Pinion John Richard · CIK 0001648096 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,764

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

F2 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document
October 12, 2021 Filed Oct 14, 2021 22:33 UTC
Dier MardiCFO & Executive Vice President
SaleCommon Stock 3,477 $82.79 $287,860.83
Disclosure

SEC source: 0001209191-21-060504 · doc4.xml · nonDerivative · entry 1

Dier Mardi · CIK 0001574591 · CFO & Executive Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,023

F1 · kind: Represents shares sold to pay required tax withholdings due to the vesting of Restricted Stock Units ("RSUs").

Read SEC document
September 30, 2021 Filed Oct 1, 2021 16:57 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 109,734 $0.00 Strike: $0.31 $0.00
Disclosure

SEC source: 0001209191-21-058365 · doc4.xml · derivative · entry 2

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 109,734 shares

Expires 2021-11-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option vested with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares thereafter such that the option fully vested on the fourth anniversary of the grant date.

Read SEC document
September 30, 2021 Filed Oct 1, 2021 16:57 UTC Exercise / conversionCommon Stock 109,734 $0.31 $34,017.54
Disclosure

SEC source: 0001209191-21-058365 · doc4.xml · nonDerivative · entry 1

Kassberg Thomas Richard · CIK 0001303811 · CBO & EVP

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 216,552

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.